Publications by authors named "V Getia"
Article Synopsis
- * From 2017 to 2022, the study evaluated HCV incidence among repeat blood donors, finding a decline in seroconversion rates from 408 to 218 per 100,000 person-years, and infection rates from 172 to 118 per 100,000 person-years.
- * The highest incidences of HCV were among males, younger adults (18-39), and those last tested in prisons, indicating a need for targeted prevention and treatment efforts in these high-risk groups in Georgia.
Background: Hepatitis C virus (HCV) infection can lead to a type of primary liver cancer called hepatocellular carcinoma (HCC). Georgia, a high HCV prevalence country, started an HCV elimination program in 2015. In addition to tracking incidence and mortality, surveillance for the HCV-attributable fraction of HCC is an important indicator of the program's impact.
View Article and Find Full Text PDFHepatitis B and hepatitis C are leading causes of cirrhosis and liver cancer and caused 1.3 million deaths worldwide in 2022. Hepatitis B is preventable with vaccination, and hepatitis C is curable with direct-acting antivirals.
View Article and Find Full Text PDFCost of SARS-CoV-2 self-test distribution programmes by different modalities: a micro-costing study in five countries (Brazil, Georgia, Malaysia, Ethiopia and the Philippines).
Megan A Hansen Nkgomeleng A Lekodeba Joshua M Chevalier Tom Ockhuisen Paula Del Rey-Puech Vladimir Getia
BMJ Open
April 2024
Article Synopsis
- The study evaluates the economic costs of providing COVID-19 self-testing in five different countries, aiming to improve access to testing three years into the pandemic.
- Results showed that the cost per self-test kit ranged from $2.44 to $12.78, influenced by the duration of implementation and demand, with a potential 50% price reduction bringing costs down to between $1.04 and $3.07.
- Key costs were largely driven by test procurement, accounting for 58-87% of expenses for off-site testing and 15-50% for on-site, with staffing costs being more significant for on-site self-testing.